- Home
- KRKR vs MRKR Comparison
KRKR vs MRKR Comparison
Compare KRKR & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRKR
- MRKR
- Stock Information
- Founded
- KRKR 2010
- MRKR N/A
- Country
- KRKR China
- MRKR United States
- Employees
- KRKR N/A
- MRKR N/A
- Industry
- KRKR Business Services
- MRKR Biotechnology: Pharmaceutical Preparations
- Sector
- KRKR Consumer Discretionary
- MRKR Health Care
- Exchange
- KRKR Nasdaq
- MRKR Nasdaq
- Market Cap
- KRKR 12.2M
- MRKR 11.6M
- IPO Year
- KRKR 2019
- MRKR N/A
- Fundamental
- Price
- KRKR $5.59
- MRKR $1.02
- Analyst Decision
- KRKR
- MRKR Strong Buy
- Analyst Count
- KRKR 0
- MRKR 3
- Target Price
- KRKR N/A
- MRKR $13.17
- AVG Volume (30 Days)
- KRKR 22.9K
- MRKR 317.3K
- Earning Date
- KRKR 09-26-2025
- MRKR 11-13-2025
- Dividend Yield
- KRKR N/A
- MRKR N/A
- EPS Growth
- KRKR N/A
- MRKR N/A
- EPS
- KRKR N/A
- MRKR N/A
- Revenue
- KRKR $30,966,526.00
- MRKR $5,388,071.00
- Revenue This Year
- KRKR $182.55
- MRKR N/A
- Revenue Next Year
- KRKR N/A
- MRKR $9.35
- P/E Ratio
- KRKR N/A
- MRKR N/A
- Revenue Growth
- KRKR N/A
- MRKR 44.55
- 52 Week Low
- KRKR $2.76
- MRKR $0.81
- 52 Week High
- KRKR $21.36
- MRKR $5.95
- Technical
- Relative Strength Index (RSI)
- KRKR 35.17
- MRKR 51.53
- Support Level
- KRKR $5.93
- MRKR $0.97
- Resistance Level
- KRKR $6.32
- MRKR $1.08
- Average True Range (ATR)
- KRKR 0.32
- MRKR 0.07
- MACD
- KRKR -0.22
- MRKR 0.01
- Stochastic Oscillator
- KRKR 0.24
- MRKR 60.50
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.